<DOC>
	<DOCNO>NCT00056368</DOCNO>
	<brief_summary>Anidulafungin medicine develop treatment patient certain kind fungal infection . These infection due yeast ( type fungus ) mouth/esophagus , blood area within body .</brief_summary>
	<brief_title>The Safety Efficacy Anidulafungin Versus Comparator Patients With Candidemia Invasive Candidiasis</brief_title>
	<detailed_description>Anidulafungin investigational drug develop intravenous treatment esophageal candidiasis , candidemia invasive fungal infection . Anidulafungin antifungal agent echinocandin class , target fungal cell wall yeast filamentous fungi .</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidemia</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Diagnosis candidemia and/or form invasive candidiasis . Should receive great 48 hour systemic antifungal therapy . Life expectancy great 72 hour . Should receive great one week prophylactic azole therapy 30 day prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Candida blood stream infection</keyword>
	<keyword>Candida infection</keyword>
	<keyword>Candidemia</keyword>
	<keyword>Invasive Candidiasis</keyword>
</DOC>